Contact us


Home > Where to invest > Regions profiles > Say yes to Kaluga

Say yes to Kaluga

Kaluga region
in numbers
Foreign investors
in Kaluga region
Featured investment sites in Kaluga region
State Autonomous Institution of Kaluga Region "Agency for Regional Development of Kaluga Region"
Director: Anna S. Kaminskaya
Address: bldg. 2, 41, Dzerzhinsky Street, Kaluga, Russia, 248001
Tel.: (4842) 27-99-90
Time zone: Moscow +0


Public and Private Partnership Centre of State Autonomous Institution of Kaluga Region "Agency for Regional Development of Kaluga Region" (PPP Centre)
Director: Anna Nikolaevna Lukina
Address: 248030, Kaluga, POB 691
Tel.: (84842) 56-07-31
Time zone: Moscow +0


OJSC "Corporation for Development of Kaluga Region"
Director: Yuriy IVANOV
Address: 248030, Kaluga, ul. Truda, 27
Tel.: (4842) 79-04-10
Time zone: Moscow +0



Palladio BNM sixth and largest plant has been launched today, with €10 million already invested the project. According to the plan, investments will reach to € 17 million level. The first stage of the plant for the Palladio Group packaging production was put into operation on June 8 in Obninsk, the Kaluga Region.
The agreement on the expansion of the production capacities for Nestlé Purina Petcare was concluded at the Peterburg International Economic Forum.
Swiss chemical concern Omya will invest 15 million euros to expand its Omya Ural enterprise to produce solid ground marble in the Kaluga Region.
Bosnalijek, a Serbian pharmaceutical manufacturer, is considering the construction of a plant in Russia, in the Kaluga region, two employees of peer companies said to Vedomosti. With the Kaluga Region being one of the options, there is no final solution, someone close to the Region’s administration says. The plant would produce solid dosage forms.
A ground-breaking ceremony of a pharmaceutical factory was held on Tuesday in Vorsino technology park located near the Russian city of Kaluga. American company Pfizer is an investor of the enterprise's building project. According to TASS news agency, the main partner of the project is NovaMedika, a portfolio company of the Russian government-owned company Rusnano engaged in the development of nanotechnology.
NovaMedica, a Russian pharmaceutical company (a portfolio company of Rosnano – TASS’ note) began construction of a plant in the Kaluga Technopark of Vorsino. The project investor is the American Pfizer.

Subscribe to Newsletters


Select a region